Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Gains from Sales and Divestitures (2022 - 2026)

Aveanna Healthcare Holdings' Gains from Sales and Divestitures history spans 4 years, with the latest figure at $5.7 million for Q1 2026.

  • For Q1 2026, Gains from Sales and Divestitures rose 728.53% year-over-year to $5.7 million; the TTM value through Jan 2026 reached $5.7 million, up 728.53%, while the annual FY2026 figure was $5.7 million, 728.53% up from the prior year.
  • Gains from Sales and Divestitures reached $5.7 million in Q1 2026 per AVAH's latest filing, up from $688865.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $5.7 million in Q1 2026 to a low of $308055.0 in Q4 2023.
  • Average Gains from Sales and Divestitures over 4 years is $1.8 million, with a median of $504959.0 recorded in 2022.
  • Peak YoY movement for Gains from Sales and Divestitures: decreased 4.05% in 2023, then skyrocketed 728.53% in 2026.
  • A 4-year view of Gains from Sales and Divestitures shows it stood at $321053.0 in 2022, then fell by 4.05% to $308055.0 in 2023, then surged by 123.62% to $688865.0 in 2024, then skyrocketed by 728.53% to $5.7 million in 2026.
  • Per Business Quant, the three most recent readings for AVAH's Gains from Sales and Divestitures are $5.7 million (Q1 2026), $688865.0 (Q4 2024), and $308055.0 (Q4 2023).